United States Capecitabine Market Report 2016

December 2016 | 103 pages | ID: UE832B68639EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Capecitabine

Revenue, means the sales value of Capecitabine

This report studies sales (consumption) of Capecitabine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Roche
• Tecoland
• ScinoPharm
• Aarti Group
• Cipla
• Intas
• Hetero
• Reliance Group
• Guike Pharmaceutical

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Capecitabine in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Capecitabine Market Report 2016

1 CAPECITABINE OVERVIEW

1.1 Product Overview and Scope of Capecitabine
1.2 Classification of Capecitabine
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Capecitabine
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Capecitabine (2011-2021)
  1.4.1 United States Capecitabine Sales and Growth Rate (2011-2021)
  1.4.2 United States Capecitabine Revenue and Growth Rate (2011-2021)

2 UNITED STATES CAPECITABINE COMPETITION BY MANUFACTURERS

2.1 United States Capecitabine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Capecitabine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Capecitabine Average Price by Manufactures (2015 and 2016)
2.4 Capecitabine Market Competitive Situation and Trends
  2.4.1 Capecitabine Market Concentration Rate
  2.4.2 Capecitabine Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CAPECITABINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Capecitabine Sales and Market Share by Type (2011-2016)
3.2 United States Capecitabine Revenue and Market Share by Type (2011-2016)
3.3 United States Capecitabine Price by Type (2011-2016)
3.4 United States Capecitabine Sales Growth Rate by Type (2011-2016)

4 UNITED STATES CAPECITABINE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Capecitabine Sales and Market Share by Application (2011-2016)
4.2 United States Capecitabine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES CAPECITABINE MANUFACTURERS PROFILES/ANALYSIS

5.1 Roche
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Capecitabine Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Roche Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Tecoland
  5.2.2 Capecitabine Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Tecoland Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 ScinoPharm
  5.3.2 Capecitabine Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 ScinoPharm Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Aarti Group
  5.4.2 Capecitabine Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Aarti Group Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Cipla
  5.5.2 Capecitabine Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Cipla Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Intas
  5.6.2 Capecitabine Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Intas Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Hetero
  5.7.2 Capecitabine Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Hetero Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Reliance Group
  5.8.2 Capecitabine Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Reliance Group Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Guike Pharmaceutical
  5.9.2 Capecitabine Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Guike Pharmaceutical Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview

6 CAPECITABINE MANUFACTURING COST ANALYSIS

6.1 Capecitabine Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Capecitabine

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Capecitabine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Capecitabine Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES CAPECITABINE MARKET FORECAST (2016-2021)

10.1 United States Capecitabine Sales, Revenue Forecast (2016-2021)
10.2 United States Capecitabine Sales Forecast by Type (2016-2021)
10.3 United States Capecitabine Sales Forecast by Application (2016-2021)
10.4 Capecitabine Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Capecitabine
Table Classification of Capecitabine
Figure United States Sales Market Share of Capecitabine by Type in 2015
Table Application of Capecitabine
Figure United States Sales Market Share of Capecitabine by Application in 2015
Figure United States Capecitabine Sales and Growth Rate (2011-2021)
Figure United States Capecitabine Revenue and Growth Rate (2011-2021)
Table United States Capecitabine Sales of Key Manufacturers (2015 and 2016)
Table United States Capecitabine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Capecitabine Sales Share by Manufacturers
Figure 2016 Capecitabine Sales Share by Manufacturers
Table United States Capecitabine Revenue by Manufacturers (2015 and 2016)
Table United States Capecitabine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Capecitabine Revenue Share by Manufacturers
Table 2016 United States Capecitabine Revenue Share by Manufacturers
Table United States Market Capecitabine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Capecitabine Average Price of Key Manufacturers in 2015
Figure Capecitabine Market Share of Top 3 Manufacturers
Figure Capecitabine Market Share of Top 5 Manufacturers
Table United States Capecitabine Sales by Type (2011-2016)
Table United States Capecitabine Sales Share by Type (2011-2016)
Figure United States Capecitabine Sales Market Share by Type in 2015
Table United States Capecitabine Revenue and Market Share by Type (2011-2016)
Table United States Capecitabine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Capecitabine by Type (2011-2016)
Table United States Capecitabine Price by Type (2011-2016)
Figure United States Capecitabine Sales Growth Rate by Type (2011-2016)
Table United States Capecitabine Sales by Application (2011-2016)
Table United States Capecitabine Sales Market Share by Application (2011-2016)
Figure United States Capecitabine Sales Market Share by Application in 2015
Table United States Capecitabine Sales Growth Rate by Application (2011-2016)
Figure United States Capecitabine Sales Growth Rate by Application (2011-2016)
Table Roche Basic Information List
Table Roche Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Capecitabine Sales Market Share (2011-2016)
Table Tecoland Basic Information List
Table Tecoland Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tecoland Capecitabine Sales Market Share (2011-2016)
Table ScinoPharm Basic Information List
Table ScinoPharm Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Table ScinoPharm Capecitabine Sales Market Share (2011-2016)
Table Aarti Group Basic Information List
Table Aarti Group Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aarti Group Capecitabine Sales Market Share (2011-2016)
Table Cipla Basic Information List
Table Cipla Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cipla Capecitabine Sales Market Share (2011-2016)
Table Intas Basic Information List
Table Intas Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intas Capecitabine Sales Market Share (2011-2016)
Table Hetero Basic Information List
Table Hetero Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hetero Capecitabine Sales Market Share (2011-2016)
Table Reliance Group Basic Information List
Table Reliance Group Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Reliance Group Capecitabine Sales Market Share (2011-2016)
Table Guike Pharmaceutical Basic Information List
Table Guike Pharmaceutical Capecitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Guike Pharmaceutical Capecitabine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Capecitabine
Figure Manufacturing Process Analysis of Capecitabine
Figure Capecitabine Industrial Chain Analysis
Table Raw Materials Sources of Capecitabine Major Manufacturers in 2015
Table Major Buyers of Capecitabine
Table Distributors/Traders List
Figure United States Capecitabine Production and Growth Rate Forecast (2016-2021)
Figure United States Capecitabine Revenue and Growth Rate Forecast (2016-2021)
Table United States Capecitabine Production Forecast by Type (2016-2021)
Table United States Capecitabine Consumption Forecast by Application (2016-2021)